| Product NDC: | 10019-321 | 
| Proprietary Name: | Flumazenil | 
| Non Proprietary Name: | Flumazenil | 
| Active Ingredient(s): | .1 mg/mL & nbsp; Flumazenil | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, SOLUTION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 10019-321 | 
| Labeler Name: | Baxter Healthcare Corporation | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA076787 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20100526 | 
| Package NDC: | 10019-321-02 | 
| Package Description: | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-321-02) > 10 mL in 1 VIAL, MULTI-DOSE (10019-321-62) | 
| NDC Code | 10019-321-02 | 
| Proprietary Name | Flumazenil | 
| Package Description | 10 VIAL, MULTI-DOSE in 1 PACKAGE (10019-321-02) > 10 mL in 1 VIAL, MULTI-DOSE (10019-321-62) | 
| Product NDC | 10019-321 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Flumazenil | 
| Dosage Form Name | INJECTION, SOLUTION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20100526 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Baxter Healthcare Corporation | 
| Substance Name | FLUMAZENIL | 
| Strength Number | .1 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | Benzodiazepine Antagonist [EPC] |